Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
210 studies found for:    "Epilepsies, Partial"
Show Display Options
RSS Create an RSS feed from your search for:
"Epilepsies, Partial"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)
Condition: Epilepsies, Partial
Interventions: Device: figure-of-eight active rTMS coil;   Device: round active rTMS coil;   Device: sham rTMS coil (figure-of-eight)
2 Completed To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
Condition: Epilepsy, Partial
Intervention: Drug: Pregabalin
3 Completed An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy
Condition: Epilepsy, Partial
Intervention: Other: no intervention
4 Completed MRI in Autosomal Dominant Partial Epilepsy With Auditory Features
Condition: Epilepsies, Partial
Intervention:
5 Completed
Has Results
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
Condition: Epilepsy, Partial
Interventions: Drug: Pregabalin;   Drug: Lamotrigine
6 Completed
Has Results
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
Condition: Epilepsy, Partial
Interventions: Drug: lamotrigine, 300 mg/day;   Drug: lamotrigine, 250 mg/day
7 Active, not recruiting Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
Condition: Partial Epilepsy
Interventions: Drug: Lacosamide;   Drug: Placebo
8 Completed Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging
Conditions: Localization-related Epilepsy;   Partial Epilepsy
Interventions: Procedure: Diffusion Tensor Imaging (DTI);   Procedure: Magnetoencephalography
9 Recruiting Brain P-gp and Inflammation in People With Epilepsy
Condition: Epilepsies, Partial
Intervention:
10 Completed Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
Condition: Epilepsy, Partial
Intervention: Drug: Levetiracetam
11 Completed Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
Condition: Epilepsy, Partial
Intervention: Drug: Levetiracetam
12 Completed Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy
Condition: Partial Epilepsy
Intervention: Drug: VX-765
13 Recruiting An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
Condition: Highly Drug-resistant Focal Epilepsy
Intervention: Drug: UCB0942
14 Completed Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
Condition: Partial Epilepsy
Intervention: Drug: Oxcarbazepine
15 Completed Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
Condition: Epilepsy, Partial
Intervention: Drug: Levetiracetam
16 Terminated EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Condition: Partial Epilepsy
Interventions: Drug: modified release formulation of oxcarbazepine (OXC MR);   Drug: immediate release formulation of oxcarbazepine (OXC IR)
17 Active, not recruiting A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
Condition: Highly Drug-resistant Focal Epilepsy
Interventions: Drug: UCB0942;   Drug: Placebo
18 Completed National Network for the Study of Predictors and Prevention of Sudden Unexpected Death in Drug-resistant Partial Epilepsies
Condition: Drug-resistant Partial Epilepsy
Intervention: Other: video-EEG
19 Completed Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
Condition: Epilepsy, Partial
Intervention: Drug: Seletracetam (ucb 44212)
20 Withdrawn Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects
Condition: Epilepsy, Partial
Intervention: Drug: Retigabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.